Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Express Scripts
Moodys
Colorcon
McKesson
Johnson and Johnson
AstraZeneca
Julphar

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for Patent: RE39221

« Back to Dashboard

Summary for Patent: RE39221
Title:Composition comprising a tramadol material and acetaminophen and its use
Abstract:This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, where the components of the compositions are within certain ratios the pharmacological effects of the compositions are superadditive (synergistic).
Inventor(s): Raffa; Robert B. (Norristown, PA), Vaught; Jeffrey L. (Glenmoore, PA)
Assignee: Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)
Application Number:10/761,096
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent RE39221
Patent Claim Types:
see list of patent claims
Composition; Use; Dosage form; Formulation;

Drugs Protected by US Patent RE39221

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent RE39221

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0566709 ➤ Sign Up 91079 Luxembourg ➤ Sign Up
European Patent Office 0566709 ➤ Sign Up SPC/GB04/012 United Kingdom ➤ Sign Up
European Patent Office 0566709 ➤ Sign Up 300152 Netherlands ➤ Sign Up
European Patent Office 0566709 ➤ Sign Up SPC023/2008 Ireland ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Federal Trade Commission
Citi
Fuji
Moodys
Fish and Richardson
Julphar
Cipla
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.